In today's vernacular, the word 'cancer' is unfortunately about as common as the word 'person'. We've all been affected by the disease... but at the University of Pennsylvania, new ground-breaking research is giving patients new hope. Tonight, pioneering researcher Dr. Bruce Levine discusses the implications of the amazing CAR-T cell research, and how he and his colleagues at the Perelman School of Medicine are creating cell technology which can empower the human body to treat its own cancers.
Dr. Bruce Levine is Deputy Director of Technology Innovation and Assessment at the Center for Cellular Immunotherapies in the University of Pennsylvania Department of Pathology and Laboratory Medicine/Perelman School of Medicine. He is also Founding Director of the Clinical Cell and Vaccine Production Facility at the University of Pennsylvania Department of Pathology and Laboratory Medicine/Perelman School of Medicine and Abramson Cancer Center. His research interests include cell, gene, and biologic therapy clinical trial development, manufacturing, and testing and lymphocyte growth, activation and senescence. Dr. Levine holds a B.A. (Major-Biology, Minor-History) from the University of Pennsylvania and a Ph.D. (Immunology and Infectious Diseases) from Johns Hopkins University.